Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast

Journal of Pathology

Volumn 180, Issue 1, 1996, Pages 44-49

  Morphopoulos, G ^a   Pearson, M ^a   Ryder, W D J ^a   Howell, A ^a   Harris, M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Breast neoplasms; Factor VIII related antigen; Immunohistochemistry; Survival

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE;

EID: 0029911399     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199609)180:1<44::AID-PATH648>3.0.CO;2-C     Document Type: Article

References (40)

1. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 1993; 10: 302-313.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1:27-31.
3. Folkman J. What is the evidence that tumors are angiogenesis dependent? (Editorial). J Natl Cancer Inst 1990; 82: 4-6.
4. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71.
5. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188.
6. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate thickness (0·76-4·0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988; 133: 419-423.
7. Macchiarini P, Fontanini G, Hardin MJ, Sqartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992; 340: 145-146.
8. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401-409.
9. Maeda K, Chung Y, Takatsuka S, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995; 13: 477-481.
10. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993; 55: 739-744.
11. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
12. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/ endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120-1124.
13. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23: 755-761.
14. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Nail Cancer Inst 1992; 84: 1875-1887.
15. Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JRT. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1992; 1: 223-229.
16. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma, Int J Cancer 1993; 55: 371-374.
17. Visscher DW, Smilanetz S, Drozdowicz S, Wykes SM. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol Histol 1993; 15: 88-92.
18. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993; 29A: 1141-1145.
19. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumor angiogenesis in node-negative breast carcinomas - relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 1994; 29: 109-116.
20. Obermair A, Czerwenka K, Kurz C, Buxbaum P, Schemper M, Sevelda P. Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: preliminary results. Onkologie 1994; 17: 44-49.
21. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and perilumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994; 12: 454-466.
22. Axelsson K, Ljung B-ME, Moore DH, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995; 87: 997-1008.
23. Goulding H, Nik Abdul Rashid NF, Robertson JF, et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 1995; 26: 1196-1200.
24. Costello P, McCann A, Carney DN, Dervan PA. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 1995; 26: 1181-1184.
25. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995; 13: 765-782.
26. Barbareschi M, Weidner N, Gasparini G, et al. Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system. Appl Immunohistochem 1995; 3: 75-84.
27. Simpson JF, Battifora H. Angiogenesis as a prognostic factor in breast cancer: can we count on it? (Editorial). Appl Immunohistochem 1995; 3: 73-74.
28. Ellis IO, Galea M, Broughton N, Locker A, Blarney RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992; 20: 479-489.
29. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 1994; 73: 1673-1677.
30. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 1979; 3: 467-488.
31. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology 1982; 6: 149-161.
32. DiCostanzo D, Rosen PP, Gareen I, Franklin S, Lesser M. Prognosis in infiltrating lobular carcinoma. An analysis of 'classical' and variant tumors. Am J Surg Pathol 1990; 14: 12-23.
33. Wheeler JE, Enterline HT. Lobular carcinoma of the breast - in situ and infiltrating. Pathol Annu 1976; 11: 161-188.
34. Harris M, Howell A, Chrissohou M, Swindell RIC, Hudson M, Sellwood RA. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23-30.
35. du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blarney RW. Invasive lobular carcinomas of the breast-the prognosis of histopathological subtypes. Br J Cancer 1989; 60: 605-609.
36. Pereira H, Pinder SE, Sibbering DM, et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 1995; 27: 219-226.
37. Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 1993; 85: 1206-1219.
38. Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis (Commentary). Lancet 1995; 346: 388-389.
39. Page DL, Dupont WD. Breast cancer angiohistogenesis: through a narrow window (Editorial). J Natl Cancer Inst 1992; 84: 1850-1851.
40. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth GHA Clowes memorial award lecture. Cancer Res 1990; 50: 6130-6138.